Clinical trials
catalyst calendar across sponsors →Studies where CNMD is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 interventional · 1 observational
Held by 10 tracked-famous managers (TWO SIGMA INVESTMENTS, LP, AQR CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, +5 more) · FINRA short interest 3.5 days to cover (settled 2026-07-31) · government filings 180d: 0 congress / 1 executive
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction ProceduresNCT06948591observationalImprovement in Function | — | Recruiting | Device: Anterior cruciate ligament reconstruction with BioBrace® augmentation · Procedure: Arthroscopic anterior cruciate ligament reconstruction | ACL Tears | 500 | Jun 2030 | ≤ 1,411 d | 2026-04-14 |
| BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff TearsNCT059973816 Month Retear RateRandomized · Single-masked · Treatment | Not applicable | Recruiting | Device: Arthroscopic rotator cuff repair with BioBrace® Implant augmentation. · Procedure: Arthroscopic rotator cuff repair | Rotator Cuff Tears | 268 | Dec 2026 | ≤ 134 d | 2026-04-23 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19